Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).

V Kunzmann, K Kelm, S Eckstein, Martin Wilhelm

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	733A-733A
Journal	BLOOD
Volume	96
Issue number	11
Publication status	Published - 2000

Cite this

Kunzmann, V., Kelm, K., Eckstein, S., & Wilhelm, M. (2000). Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). BLOOD , 96(11), 733A-733A.

Kunzmann, V ; Kelm, K ; Eckstein, S et al. / Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). In: BLOOD 2000 ; Vol. 96, No. 11. pp. 733A-733A.

@article{abcabd9a33a84c3fa06936f4b6729b00,

title = "Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).",

author = "V Kunzmann and K Kelm and S Eckstein and Martin Wilhelm",

year = "2000",

language = "English",

volume = "96",

pages = "733A--733A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

}

Kunzmann, V, Kelm, K, Eckstein, S & Wilhelm, M 2000, 'Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).', BLOOD , vol. 96, no. 11, pp. 733A-733A.

Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). / Kunzmann, V; Kelm, K; Eckstein, S et al.
In: BLOOD , Vol. 96, No. 11, 2000, p. 733A-733A.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL).

AU - Kunzmann, V

AU - Kelm, K

AU - Eckstein, S

AU - Wilhelm, Martin

PY - 2000

Y1 - 2000

M3 - Abstract (Journal)

SN - 0006-4971

VL - 96

SP - 733A-733A

JO - BLOOD

JF - BLOOD

IS - 11

ER -

Kunzmann V, Kelm K, Eckstein S, Wilhelm M. Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkinxxxs lymphoma (NHL). BLOOD . 2000;96(11):733A-733A.